Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV002474282 | SCV002770755 | uncertain significance | not provided | 2022-08-02 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV002474282 | SCV003830892 | uncertain significance | not provided | 2023-01-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV005333250 | SCV005999126 | uncertain significance | Inborn genetic diseases | 2025-02-07 | criteria provided, single submitter | clinical testing | The c.5054G>C (p.C1685S) alteration is located in exon 45 (coding exon 45) of the DYSF gene. This alteration results from a G to C substitution at nucleotide position 5054, causing the cysteine (C) at amino acid position 1685 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |